Cargando…
Feasibility and toxicity of hematopoietic stem cell transplant in multiple sclerosis
Multiple sclerosis is a debilitating disease of the central nervous system. It affects people of all ages but is more prevalent among 20-40 year olds. Patients with MS can be presented with potentially any neurological symptom depending on the location of the lesion. A quarter of patients with MS su...
Autores principales: | Kuan, Thomas Low Tat, Amini, Farahnaz, Seghayat, Marjan Sadat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569597/ https://www.ncbi.nlm.nih.gov/pubmed/28852436 http://dx.doi.org/10.22038/IJBMS.2017.9000 |
Ejemplares similares
-
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis
por: Thebault, Simon, et al.
Publicado: (2020) -
Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
por: Pandit, Awadh Kishor, et al.
Publicado: (2015) -
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
por: Bakhuraysah, Maha M., et al.
Publicado: (2016) -
Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018) -
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2017)